118 related articles for article (PubMed ID: 12007425)
1. Treatment fillip for gene therapy ambitions.
Williams N
Curr Biol; 2002 Apr; 12(9):R305-6. PubMed ID: 12007425
[No Abstract] [Full Text] [Related]
2. Hemophilia. After a setback, gene therapy progresses...gingerly.
Gura T
Science; 2001 Mar; 291(5509):1692-7. PubMed ID: 11253191
[No Abstract] [Full Text] [Related]
3. [Gene therapy and clinical trials].
Tazawa R; Pradono P; Hagiwara K; Nukiwa T
Nihon Rinsho; 2002 May; 60 Suppl 5():625-9. PubMed ID: 12101750
[No Abstract] [Full Text] [Related]
4. Hemophilia Gene Therapy: Caught Between a Cure and an Immune Response.
Herzog RW
Mol Ther; 2015 Sep; 23(9):1411-2. PubMed ID: 26321180
[No Abstract] [Full Text] [Related]
5. Gene therapy. The best of times, the worst of times.
Anderson WF
Science; 2000 Apr; 288(5466):627-9. PubMed ID: 10799000
[No Abstract] [Full Text] [Related]
6. [Gene therapy of hemophilia].
Watzke HH
Internist (Berl); 2001 Oct; 42(10):1366-8, 1371-3. PubMed ID: 11688155
[No Abstract] [Full Text] [Related]
7. Gene therapy. Side effects sideline hemophilia trial.
Kaiser J
Science; 2004 Jun; 304(5676):1423-5. PubMed ID: 15178771
[No Abstract] [Full Text] [Related]
8. AAV vectors, the future workhorse of human gene therapy.
Samulski RJ
Ernst Schering Res Found Workshop; 2003; (43):25-40. PubMed ID: 12894449
[No Abstract] [Full Text] [Related]
9. Gene therapy as a new treatment option for inherited monogenic diseases.
Boudes PF
Eur J Intern Med; 2014 Jan; 25(1):31-6. PubMed ID: 24129166
[TBL] [Abstract][Full Text] [Related]
10. Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges.
Raj D; Davidoff AM; Nathwani AC
Expert Rev Hematol; 2011 Oct; 4(5):539-49. PubMed ID: 21939421
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy. Panel reviews risks of germ line changes.
Marshall E
Science; 2001 Dec; 294(5550):2268-9. PubMed ID: 11743173
[No Abstract] [Full Text] [Related]
12. For gene therapy, now-quantified risks are deemed troubling.
Twombly R
J Natl Cancer Inst; 2003 Jul; 95(14):1032-3. PubMed ID: 12865444
[No Abstract] [Full Text] [Related]
13. Gene therapy for hemophilia B: AAV-mediated transfer of the gene for coagulation factor IX to human muscle.
Larson PJ; High KA
Adv Exp Med Biol; 2001; 489():45-57. PubMed ID: 11554590
[No Abstract] [Full Text] [Related]
14. Gene therapy: Genie in a vector.
Gould J
Nature; 2014 Nov; 515(7528):S160-1. PubMed ID: 25427205
[No Abstract] [Full Text] [Related]
15. Adeno-associated vectors: are we there yet?
Walsh CE
Gene Ther; 2005 Nov; 12(21):1539. PubMed ID: 18360946
[No Abstract] [Full Text] [Related]
16. Immune responses to AAV capsid: are mice not humans after all?
Herzog RW
Mol Ther; 2007 Apr; 15(4):649-50. PubMed ID: 17372595
[No Abstract] [Full Text] [Related]
17. Clinical progress in gene therapy: sustained partial correction of the bleeding disorder in patients suffering from severe hemophilia B.
Vandendriessche T; Chuah MK
Hum Gene Ther; 2012 Jan; 23(1):4-6. PubMed ID: 22149214
[No Abstract] [Full Text] [Related]
18. The gene therapy journey for hemophilia: are we there yet?
High KA
Hematology Am Soc Hematol Educ Program; 2012; 2012():375-81. PubMed ID: 23233607
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy. Viral vectors still pack surprises.
Marshall E
Science; 2001 Nov; 294(5547):1640. PubMed ID: 11721031
[No Abstract] [Full Text] [Related]
20. Perspective: The fix is in.
Pemberton S
Nature; 2014 Nov; 515(7528):S165. PubMed ID: 25427207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
